✦ LIBER ✦

Phase I/II Trial of Lenalidomide and High-Dose Melphalan As Preparative Regimen for Relapsed Myeloma

✍ Scribed by Qazilbash, Muzaffar H.; Thall, Peter; Fox, Patricia S.; Shah, Nina; Bashir, Qaiser; Shah, Jatin; Parmar, Simrit; Kebriaei, Partow; Nieto, Yago; Dinh, Yvonne; Popat, Uday R.; Hosing, Chitra; Lin, Pei; Shpall, Elizabeth J.; Orlowski, Robert; Champlin, Richard E.

Book ID: 122188940
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 51 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.12.044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A333 Phase I/II Trial of Cyclophosphamid

A333 Phase I/II Trial of Cyclophosphamide, Prednisone, and Lenalidomide for Relapsed and Refractory MM

✍ Reece, D; Masih-Khan, E; Anglin, P; Chen, C; Kukreti, V; Khan, A; Mikhael, J; Tr 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 85 KB

Phase I/II Trial Assessing Bortezomib an

Phase I/II Trial Assessing Bortezomib and Melphalan Combination Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

✍ Berenson, J. R. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 103 KB

A Phase I Study Of Clofarabine Plus High

A Phase I Study Of Clofarabine Plus High Dose Melphalan As A Conditioning Regimen For Allogeneic Transplantation

✍ M.H. Kirschbaum; A.S. Stein; R. Nakamura; N. Auayporn; L. Popplewell; M. Deliouk 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

High-dose melphalan versus busulfan, cyc

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Busulfan and Cyclophosphamide has Simila

Busulfan and Cyclophosphamide has Similar Outcomes to High Dose Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation In Patients With Multiple Myeloma

✍ A. Mahindra; B. Bolwell; L. Rybicki; R. Dean; B. Pohlman; R. Sobecks; S. Andrese 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A Phase II study of 153Sm-EDTMP and high

A Phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

✍ Angela Dispenzieri; Gregory A. Wiseman; Martha Q. Lacy; Suzanne R. Hayman; Shaji 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views